Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q59693241 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000205.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q59693241 | ||
| 024 | ‡a 0000-0002-2663-7515 ‡2 orcid | ||
| 024 | ‡a 56779836700 ‡2 scopus | ||
| 024 | ‡a 56808523000 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q59693241 | ||
| 100 | 0 | ‡a Ning Wang ‡c researcher ORCID ID = 0000-0002-2663-7515 ‡9 en | |
| 670 | ‡a Author's Inhibiting the P2X4 Receptor Suppresses Prostate Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target | ||
| 670 | ‡a Author's Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancer. | ||
| 670 | ‡a Author's Mouse models for studying prostate cancer bone metastasis. | ||
| 670 | ‡a Author's P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis. | ||
| 670 | ‡a Author's Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast Cancer | ||
| 670 | ‡a Author's Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models | ||
| 670 | ‡a Author's Purification and characterization of trypsin-like enzymes from North Pacific krill (Euphausia pacifica) | ||
| 670 | ‡a Author's Purinergic signalling in bone | ||
| 670 | ‡a Author's Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. | ||
| 670 | ‡a Author's Role of the P2X7 receptor in the osteogenic differentiation of mesenchymal cells and in osteoclast fusion: presented by: Maria P. Abbracchio. | ||
| 670 | ‡a Author's Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes | ||
| 670 | ‡a Author's RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis | ||
| 670 | ‡a Author's Targeting P2 receptors--current progress in treating musculoskeletal diseases | ||
| 670 | ‡a Author's The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer | ||
| 670 | ‡a Author's The P2Y(6) receptor stimulates bone resorption by osteoclasts. | ||
| 670 | ‡a Author's The P2Y13 receptor regulates phosphate metabolism and FGF-23 secretion with effects on skeletal development | ||
| 670 | ‡a Author's Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo | ||
| 909 | ‡a (scopus) 56779836700 ‡9 1 | ||
| 909 | ‡a (scopus) 56808523000 ‡9 1 | ||
| 909 | ‡a (orcid) 0000000226637515 ‡9 1 | ||
| 919 | ‡a inhibitingthep2x4receptorsuppressesprostatecancergrowthinvitroandinvivosuggestingapotentialclinicaltarget ‡A Inhibiting the P2X4 Receptor Suppresses Prostate Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target ‡9 1 | ||
| 919 | ‡a mitoticquiescencebutnotuniquestemnessmarksthephenotypeofbonemetastasisinitiatingcellsinprostatecancer ‡A Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancer. ‡9 1 | ||
| 919 | ‡a mousemodelsforstudyingprostatecancerbonemetastasis ‡A Mouse models for studying prostate cancer bone metastasis. ‡9 1 | ||
| 919 | ‡a p2x7receptorregulatesosteoclastfunctionandbonelossinamousemodelofosteoporosis ‡A P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis. ‡9 1 | ||
| 919 | ‡a parathyroidhormonepthincreasesskeletaltumourgrowthandalterstumourdistributioninaninvivomodelofbreastcancer ‡A Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast Cancer ‡9 1 | ||
| 919 | ‡a prostatecancercellspreferentiallyhometoosteoblastrichareasintheearlystagesofbonemetastasisevidencefrominvivomodels ‡A Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models ‡9 1 | ||
| 919 | ‡a purificationandcharacterizationoftrypsinlikeenzymesfromnorthpacifickrilleuphausiapacifica ‡A Purification and characterization of trypsin-like enzymes from North Pacific krill (Euphausia pacifica) ‡9 1 | ||
| 919 | ‡a purinergicsignallinginbone ‡A Purinergic signalling in bone ‡9 1 | ||
| 919 | ‡a reducedboneturnoverinmicelackingthep2y13receptorofadp ‡A Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. ‡9 1 | ||
| 919 | ‡a roleofthep2x7receptorintheosteogenicdifferentiationofmesenchymalcellsandinosteoclastfusionpresentedbymariapabbracchio ‡A Role of the P2X7 receptor in the osteogenic differentiation of mesenchymal cells and in osteoclast fusion: presented by: Maria P. Abbracchio. ‡9 1 | ||
| 919 | ‡a roleofthep2y13receptorinthedifferentiationofbonemarrowstromalcellsintoosteoblastsandadipocytes ‡A Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes ‡9 1 | ||
| 919 | ‡a rspo2andranklsignalthroughlgr4toregulateosteoclasticpremetastaticnicheformationandbonemetastasis ‡A RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis ‡9 1 | ||
| 919 | ‡a targetingp2receptorscurrentprogressintreatingmusculoskeletaldiseases ‡A Targeting P2 receptors--current progress in treating musculoskeletal diseases ‡9 1 | ||
| 919 | ‡a frequencyofosteolyticbonemetastasisisdeterminedbyconditionsofthesoilnotthenumberofseedsevidencefrominvivomodelsofbreastandprostatecancer ‡A The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer ‡9 1 | ||
| 919 | ‡a p2y6receptorstimulatesboneresorptionbyosteoclasts ‡A The P2Y(6) receptor stimulates bone resorption by osteoclasts. ‡9 1 | ||
| 919 | ‡a p2y13receptorregulatesphosphatemetabolismandfgf23secretionwitheffectsonskeletaldevelopment ‡A The P2Y13 receptor regulates phosphate metabolism and FGF-23 secretion with effects on skeletal development ‡9 1 | ||
| 919 | ‡a zoledronicacidhasdifferentialantitumoractivityinthepreandpostmenopausalbonemicroenvironmentinvivo ‡A Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo ‡9 1 | ||
| 996 | ‡2 ISNI|0000000063932041 | ||
| 996 | ‡2 CYT|AC000007531 | ||
| 996 | ‡2 SUDOC|256851247 | ||
| 996 | ‡2 ISNI|0000000089795372 | ||
| 996 | ‡2 ISNI|0000000052670007 | ||
| 996 | ‡2 LC|nr 92003682 | ||
| 996 | ‡2 NSK|000673924 | ||
| 996 | ‡2 DNB|1336729414 | ||
| 996 | ‡2 CYT|AC000008377 | ||
| 996 | ‡2 CYT|AC000207485 | ||
| 996 | ‡2 NTA|074987097 | ||
| 996 | ‡2 ISNI|0000000356883116 | ||
| 996 | ‡2 ISNI|0000000064115094 | ||
| 996 | ‡2 SUDOC|123482984 | ||
| 996 | ‡2 DNB|141260211 | ||
| 996 | ‡2 LC|n 2013011938 | ||
| 996 | ‡2 LC|no2016163712 | ||
| 996 | ‡2 NTA|171555392 | ||
| 996 | ‡2 LC|nb2023011981 | ||
| 996 | ‡2 NTA|227466985 | ||
| 996 | ‡2 LC|n 2010065502 | ||
| 996 | ‡2 NTA|143224239 | ||
| 996 | ‡2 NTA|344696251 | ||
| 996 | ‡2 LC|no2020083522 | ||
| 996 | ‡2 BNF|17764160 | ||
| 996 | ‡2 NII|DA11517540 | ||
| 996 | ‡2 DNB|106505856X | ||
| 996 | ‡2 CYT|AC000223446 | ||
| 996 | ‡2 ISNI|0000000048308638 | ||
| 996 | ‡2 DNB|1184491739 | ||
| 996 | ‡2 RERO|A026018720 | ||
| 996 | ‡2 DNB|1323686614 | ||
| 996 | ‡2 NDL|001130754 | ||
| 996 | ‡2 ISNI|0000000459821938 | ||
| 996 | ‡2 DNB|1217738878 | ||
| 996 | ‡2 LC|nb2018008482 | ||
| 996 | ‡2 NII|DA17516937 | ||
| 996 | ‡2 LC|n 2020038161 | ||
| 996 | ‡2 LC|nr 96015743 | ||
| 996 | ‡2 NKC|jo2014801944 | ||
| 996 | ‡2 CYT|AC000008697 | ||
| 996 | ‡2 LC|nr 90001821 | ||
| 996 | ‡2 NLA|000035667178 | ||
| 996 | ‡2 LC|n 82027131 | ||
| 996 | ‡2 LC|n 2013014353 | ||
| 996 | ‡2 ISNI|0000000072821562 | ||
| 996 | ‡2 DNB|1316061493 | ||
| 996 | ‡2 RERO|A022413015 | ||
| 996 | ‡2 CYT|AC000577306 | ||
| 996 | ‡2 CYT|AC000000648 | ||
| 996 | ‡2 RERO|A027403771 | ||
| 996 | ‡2 CYT|AC000208947 | ||
| 996 | ‡2 CYT|AC000655467 | ||
| 996 | ‡2 ISNI|0000000076426498 | ||
| 996 | ‡2 DNB|17244215X | ||
| 996 | ‡2 ISNI|0000000064246844 | ||
| 996 | ‡2 CYT|AC000207030 | ||
| 996 | ‡2 DNB|142639524 | ||
| 996 | ‡2 CYT|AC000369750 | ||
| 996 | ‡2 LC|n 81017441 | ||
| 996 | ‡2 CYT|AC000208575 | ||
| 996 | ‡2 SUDOC|272934658 | ||
| 996 | ‡2 ISNI|0000000092866987 | ||
| 996 | ‡2 CYT|AC000210362 | ||
| 996 | ‡2 SUDOC|224830686 | ||
| 996 | ‡2 LC|n 2011019281 | ||
| 996 | ‡2 LC|n 2017046255 | ||
| 996 | ‡2 LC|nb2014008456 | ||
| 996 | ‡2 NTA|242579418 | ||
| 996 | ‡2 ISNI|0000000497219251 | ||
| 996 | ‡2 DNB|1257700421 | ||
| 996 | ‡2 J9U|987007420550205171 | ||
| 996 | ‡2 ISNI|0000000095570532 | ||
| 996 | ‡2 DNB|1161768610 | ||
| 996 | ‡2 LC|n 2012040883 | ||
| 996 | ‡2 BNF|17112092 | ||
| 996 | ‡2 SUDOC|16038401X | ||
| 996 | ‡2 LC|no2014081512 | ||
| 996 | ‡2 ISNI|0000000118700599 | ||
| 996 | ‡2 PLWABN|9810701698205606 | ||
| 996 | ‡2 LC|n 88005816 | ||
| 996 | ‡2 BNF|16685976 | ||
| 996 | ‡2 LC|n 2012046298 | ||
| 996 | ‡2 J9U|987007389551105171 | ||
| 996 | ‡2 BNF|18109630 | ||
| 996 | ‡2 SELIBR|371216 | ||
| 996 | ‡2 DNB|171913329 | ||
| 996 | ‡2 SUDOC|243708432 | ||
| 996 | ‡2 NII|DA08572573 | ||
| 996 | ‡2 DNB|1021405035 | ||
| 996 | ‡2 ISNI|0000000064152477 | ||
| 996 | ‡2 DNB|1126998699 | ||
| 996 | ‡2 NTA|364181389 | ||
| 996 | ‡2 DNB|1196050422 | ||
| 996 | ‡2 DNB|1203722028 | ||
| 996 | ‡2 W2Z|1522228657590 | ||
| 996 | ‡2 SUDOC|163987092 | ||
| 996 | ‡2 CYT|AC000399629 | ||
| 996 | ‡2 ISNI|0000000388952630 | ||
| 996 | ‡2 LC|n 94062682 | ||
| 996 | ‡2 BIBSYS|90761453 | ||
| 996 | ‡2 LC|nr 91023522 | ||
| 996 | ‡2 ISNI|000000042841175X | ||
| 996 | ‡2 DNB|1170781500 | ||
| 996 | ‡2 NTA|372644872 | ||
| 996 | ‡2 NSK|000422144 | ||
| 996 | ‡2 BNF|14504559 | ||
| 996 | ‡2 PLWABN|9810609456805606 | ||
| 996 | ‡2 LC|n 89111271 | ||
| 996 | ‡2 DNB|1140152777 | ||
| 996 | ‡2 J9U|987007318672405171 | ||
| 996 | ‡2 ISNI|0000000371452242 | ||
| 996 | ‡2 NTA|364170689 | ||
| 996 | ‡2 CAOONL|ncf10635900 | ||
| 996 | ‡2 W2Z|1522228657599 | ||
| 996 | ‡2 BIBSYS|90262784 | ||
| 996 | ‡2 DNB|1336647507 | ||
| 996 | ‡2 LC|n 2017006788 | ||
| 996 | ‡2 CYT|AC000549757 | ||
| 996 | ‡2 LC|nb2019017867 | ||
| 996 | ‡2 SZ|1170781500 | ||
| 996 | ‡2 CAOONL|ncf10717429 | ||
| 996 | ‡2 SUDOC|130643475 | ||
| 996 | ‡2 CYT|AC000000241 | ||
| 996 | ‡2 DNB|1023677687 | ||
| 996 | ‡2 ISNI|0000000486409391 | ||
| 996 | ‡2 ISNI|0000000505841332 | ||
| 996 | ‡2 ISNI|0000000381557726 | ||
| 996 | ‡2 LC|n 2008014858 | ||
| 996 | ‡2 RERO|A016608443 | ||
| 996 | ‡2 LC|nr 90026900 | ||
| 996 | ‡2 NSK|000633491 | ||
| 996 | ‡2 ISNI|0000000084517699 | ||
| 996 | ‡2 CAOONL|ncf10488677 | ||
| 996 | ‡2 NUKAT|n 2012172983 | ||
| 996 | ‡2 NTA|151471770 | ||
| 996 | ‡2 CAOONL|ncf10588092 | ||
| 996 | ‡2 ISNI|0000000444592917 | ||
| 996 | ‡2 DNB|119040123 | ||
| 996 | ‡2 DNB|1126653756 | ||
| 996 | ‡2 ISNI|000000037343729X | ||
| 996 | ‡2 DNB|1243914769 | ||
| 996 | ‡2 DNB|115043869X | ||
| 996 | ‡2 SUDOC|202426017 | ||
| 996 | ‡2 NSK|000550664 | ||
| 996 | ‡2 ISNI|0000000420516821 | ||
| 996 | ‡2 J9U|987007269501305171 | ||
| 996 | ‡2 DNB|141165197 | ||
| 996 | ‡2 CYT|AC000004498 | ||
| 996 | ‡2 BIBSYS|1522228657592 | ||
| 996 | ‡2 CYT|AC000008333 | ||
| 996 | ‡2 DNB|122240111 | ||
| 996 | ‡2 LC|nr 99000788 | ||
| 996 | ‡2 CAOONL|ncf10344116 | ||
| 996 | ‡2 BIBSYS|1522228657599 | ||
| 996 | ‡2 ISNI|0000000454983890 | ||
| 996 | ‡2 LC|n 2012060048 | ||
| 996 | ‡2 NUKAT|n 2013126809 | ||
| 996 | ‡2 LC|no2009187250 | ||
| 996 | ‡2 CYT|AC000605007 | ||
| 996 | ‡2 NYNYRILM|92074 | ||
| 996 | ‡2 ISNI|0000000064217007 | ||
| 996 | ‡2 BIBSYS|49669 | ||
| 996 | ‡2 DNB|1139860445 | ||
| 996 | ‡2 NSK|000524368 | ||
| 996 | ‡2 ISNI|0000000505840348 | ||
| 996 | ‡2 ISNI|0000000064085016 | ||
| 996 | ‡2 ISNI|0000000436168999 | ||
| 996 | ‡2 LC|no2001003470 | ||
| 996 | ‡2 DNB|1069852619 | ||
| 996 | ‡2 LC|no2023139452 | ||
| 996 | ‡2 RERO|A000175057 | ||
| 996 | ‡2 DNB|1223676013 | ||
| 996 | ‡2 NTA|298810336 | ||
| 996 | ‡2 J9U|987007337463005171 | ||
| 996 | ‡2 KRNLK|KAC200305382 | ||
| 996 | ‡2 NSK|000566236 | ||
| 996 | ‡2 DNB|1317037987 | ||
| 996 | ‡2 LC|nr 91044489 | ||
| 996 | ‡2 PLWABN|9810672386405606 | ||
| 996 | ‡2 DNB|1204106649 | ||
| 996 | ‡2 J9U|987007315418805171 | ||
| 996 | ‡2 LC|n 2013066456 | ||
| 996 | ‡2 BNF|18047128 | ||
| 996 | ‡2 CYT|AC000207612 | ||
| 996 | ‡2 ISNI|0000000512428730 | ||
| 996 | ‡2 SUDOC|176717072 | ||
| 996 | ‡2 LC|n 2012000938 | ||
| 996 | ‡2 LC|n 2012075877 | ||
| 996 | ‡2 CAOONL|ncf11060558 | ||
| 996 | ‡2 DNB|1176975714 | ||
| 996 | ‡2 ISNI|0000000070592188 | ||
| 996 | ‡2 CYT|AC000401072 | ||
| 996 | ‡2 DNB|1205377786 | ||
| 996 | ‡2 ISNI|000000038259932X | ||
| 996 | ‡2 DNB|1273780833 | ||
| 996 | ‡2 NTA|27954216X | ||
| 996 | ‡2 LC|n 2017023448 | ||
| 996 | ‡2 DNB|125635595X | ||
| 996 | ‡2 BIBSYS|1522228657590 | ||
| 996 | ‡2 W2Z|1522228657592 | ||
| 996 | ‡2 ISNI|0000000464128943 | ||
| 996 | ‡2 ISNI|0000000075819126 | ||
| 996 | ‡2 W2Z|49669 | ||
| 996 | ‡2 LC|no2024045971 | ||
| 996 | ‡2 LC|n 82116873 | ||
| 996 | ‡2 LC|nb2013026989 | ||
| 996 | ‡2 W2Z|1523345889083 | ||
| 996 | ‡2 NSK|000566234 | ||
| 996 | ‡2 CYT|AC000224170 | ||
| 996 | ‡2 LC|no2009056074 | ||
| 996 | ‡2 LC|n 2020004117 | ||
| 996 | ‡2 CYT|AC000007794 | ||
| 996 | ‡2 BIBSYS|90247743 | ||
| 996 | ‡2 ISNI|0000000394976241 | ||
| 996 | ‡2 DNB|1207842613 | ||
| 996 | ‡2 NUKAT|n 2018290615 | ||
| 996 | ‡2 DNB|1188374761 | ||
| 996 | ‡2 NKC|jo20181015016 | ||
| 996 | ‡2 DNB|1343610206 | ||
| 996 | ‡2 LNB|LNC10-000188330 | ||
| 996 | ‡2 CYT|AC000207747 | ||
| 996 | ‡2 DNB|1042691738 | ||
| 996 | ‡2 ISNI|0000000029797392 | ||
| 996 | ‡2 DNB|1254169210 | ||
| 996 | ‡2 ISNI|0000000064272954 | ||
| 996 | ‡2 NYNYRILM|293724 | ||
| 996 | ‡2 NYNYRILM|293723 | ||
| 996 | ‡2 CYT|AC000208503 | ||
| 996 | ‡2 SUDOC|134257529 | ||
| 996 | ‡2 DNB|1207176699 | ||
| 996 | ‡2 ISNI|0000000063800380 | ||
| 996 | ‡2 NTA|364181974 | ||
| 996 | ‡2 J9U|987007355177505171 | ||
| 996 | ‡2 LC|n 2004111475 | ||
| 996 | ‡2 SUDOC|154837881 | ||
| 996 | ‡2 DNB|1337161411 | ||
| 996 | ‡2 CYT|AC000007827 | ||
| 996 | ‡2 LC|no2013001625 | ||
| 996 | ‡2 NTA|387595376 | ||
| 996 | ‡2 DNB|1219942758 | ||
| 996 | ‡2 LNB|LNC10-000118074 | ||
| 996 | ‡2 NTA|155971484 | ||
| 996 | ‡2 CYT|AC000212439 | ||
| 996 | ‡2 DNB|130455091 | ||
| 996 | ‡2 LC|n 2011077169 | ||
| 996 | ‡2 LC|n 2013003012 | ||
| 996 | ‡2 CYT|AC000007995 | ||
| 996 | ‡2 LC|no2016008296 | ||
| 996 | ‡2 LC|n 2013005980 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
